Comparison of Magnetic Resonance Imaging Mismatch Criteria to Select Patients for Endovascular Stroke Therapy Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 Investigators
暂无分享,去创建一个
R. Bammer | M. Straka | M. Mlynash | S. Kemp | G. Albers | M. Lansberg | S. Christensen | John T. P. Liggins | N. Mishra | Michael Marks | Scott Hamilton | M. Marks
[1] M. Siket,et al. Treatment of Acute Ischemic Stroke. , 2016, Emergency medicine clinics of North America.
[2] R. Bammer,et al. Patients with Single Distal MCA Perfusion Lesions Have a High Rate of Good Outcome with or without Reperfusion , 2014, International journal of stroke : official journal of the International Stroke Society.
[3] G. Zaharchuk,et al. ( DEFUSE 2 ) Investigators for Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 , 2014 .
[4] Max Wintermark,et al. A trial of imaging selection and endovascular treatment for ischemic stroke. , 2013, The New England journal of medicine.
[5] Manabu Inoue,et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study , 2012, The Lancet Neurology.
[6] R. Gonzalez,et al. Clinical MRI of acute ischemic stroke , 2012, Journal of magnetic resonance imaging : JMRI.
[7] Geoffrey A. Donnan,et al. RAPID Automated Patient Selection for Reperfusion Therapy: A Pooled Analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study , 2011, Stroke.
[8] R. Bammer,et al. Real‐time diffusion‐perfusion mismatch analysis in acute stroke , 2010, Journal of magnetic resonance imaging : JMRI.
[9] AlexAbou-Chebl. Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients , 2010 .
[10] A. Abou-Chebl,et al. Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients , 2010, Stroke.
[11] Alan Connelly,et al. The Physiological Significance of the Time-to-Maximum (Tmax) Parameter in Perfusion MRI , 2010, Stroke.
[12] Gregory W Albers,et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials , 2010, The Lancet.
[13] W. Hacke,et al. Mismatch-Based Delayed Thrombolysis: A Meta-Analysis , 2010, Stroke.
[14] R. Gonzalez,et al. MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization , 2009, Stroke.
[15] S. Warach,et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study , 2009, The Lancet Neurology.
[16] R. Hakimelahi,et al. Neuroimaging of ischemic stroke with CT and MRI: advancing towards physiology-based diagnosis and therapy , 2009, Expert review of cardiovascular therapy.
[17] R. Bammer,et al. The MRA-DWI Mismatch Identifies Patients With Stroke Who Are Likely to Benefit From Reperfusion , 2008, Stroke.
[18] Keith Muir,et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.
[19] M. Moseley,et al. Optimal Definition for PWI/DWI Mismatch in Acute Ischemic Stroke Patients , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] Scott Hamilton,et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.
[21] Steven Warach,et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset , 2006, Stroke.
[22] S. Warach,et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase , 2005, Stroke.
[23] J. Alger,et al. Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging , 2003, Stroke.
[24] G. Albers,et al. Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. , 1999, Stroke.